Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | CDC25B | P30305 | 1/20 | 0.33 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.33 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL868289 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CDC25BTRIM24TRIM33CYP2A6 | |
| SCHEMBL868287 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CDC25BTRIM24TRIM33CYP2A6 | |
| SCHEMBL3262868 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CDC25BTRIM24TRIM33CYP2A6 | |
| SCHEMBL3259171 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CDC25BTRIM24TRIM33CYP2A6 | |
| SCHEMBL4619035 | 0.98 | ALDH1A1 (0.48) | ALDH1A1CDC25BTRIM24TRIM33CA1 | |
| SCHEMBL4619030 | 0.98 | ALDH1A1 (0.48) | ALDH1A1CDC25BTRIM24TRIM33CA1 | |
| SCHEMBL3334082 | 0.90 | — | — | |
| SCHEMBL3682073 | 0.86 | ALDH1A1 (0.38) | ALDH1A1CDC25BTRIM24TRIM33 | |
| SCHEMBL2678350 | 0.84 | ALDH1A1 (0.44) | ALDH1A1CDC25BTRIM24TRIM33CA1 | |
| SCHEMBL2678345 | 0.84 | ALDH1A1 (0.44) | ALDH1A1CDC25BTRIM24TRIM33CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2391597-B1 | METHOD FOR PRODUCING PURE CYCLODODECANONE | BASF SE (DE) | 2018-08-22 | — | — | EP | disclosed |
| EP-2391596-B1 | METHOD FOR ISOLATING DODECATRIENAL AND USE THEREOF AS A FLAVOURING | BASF SE (DE) | 2018-06-20 | — | — | EP | disclosed |
| US-8212082-B2 | Process for the isolation of dodecatrienal and its use as aroma substance | BASF SE (DE) | 2012-07-03 | — | — | US | disclosed |
| US-8188320-B2 | Process for preparing pure cyclododecanone | BASF SE (DE) | 2012-05-29 | — | — | US | disclosed |
| EP-2391597-A1 | METHOD FOR PRODUCING PURE CYCLODODECANONE | BASF SE (DE) | 2011-12-07 | — | — | EP | disclosed |
| EP-2391596-A1 | METHOD FOR ISOLATING DODECATRIENAL AND USE THEREOF AS A FLAVOURING | BASF SE (DE) | 2011-12-07 | — | — | EP | disclosed |
| WO-2010086313-A1 | METHOD FOR ISOLATING DODECATRIENAL AND USE THEREOF AS A FLAVOURING | BASF SE (DE) | 2010-08-05 | — | — | WO | disclosed |
| WO-2010086314-A1 | METHOD FOR PRODUCING PURE CYCLODODECANONE | BASF SE (DE) | 2010-08-05 | — | — | WO | disclosed |
| US-20100190869-A1 | PROCESS FOR THE ISOLATION OF DODECATRIENAL AND ITS USE AS AROMA SUBSTANCE | BASF SE (DE) | 2010-07-29 | — | — | US | disclosed |
| US-20100191018-A1 | PROCESS FOR PREPARING PURE CYCLODODECANONE | BASF SE (DE) | 2010-07-29 | — | — | US | disclosed |
| US-7692045-B2 | Method for purifying and concentrating dinitrogen monoxide | BASF AKTIENGESELLSCHAFT (DE) | 2010-04-06 | — | — | US | disclosed |
| US-7649119-B2 | Method for the production of cyclic ketones | BASF SE (DE) | 2010-01-19 | — | — | US | disclosed |
| US-20090326276-A1 | METHOD FOR THE PRODUCTION OF CYCLIC KETONES | BASF SE (DE) | 2009-12-31 | — | — | US | disclosed |
| EP-2041060-B1 | METHOD FOR THE PRODUCTION OF CYCLIC KETONES | BASF SE (DE) | 2009-12-16 | — | — | EP | disclosed |
| US-20090281357-A1 | METHOD FOR THE PRODUCTION OF CYCLIC KETONES | BASF SE (DE) | 2009-11-12 | — | — | US | disclosed |
| EP-2041060-A1 | METHOD FOR THE PRODUCTION OF CYCLIC KETONES | BASF SE (DE) | 2009-04-01 | — | — | EP | disclosed |
| US-7449606-B2 | reacting cyclododecatriene with dinitrogen monoxide to obtain cyclododecadienone and hydrogenating the resulting cyclododecadienone; in particular to give cyclododecanone an important intermediate for the preparation of, for example, laurolactam | BASF SE (DE) | 2008-11-11 | — | — | US | disclosed |
| US-20080255393-A1 | Method for Purifying and Concentrating Dinitrogen Monoxide | BASF AKTIENGESELLSCHAFT (DE) | 2008-10-16 | — | — | US | disclosed |
| WO-2008000757-A1 | METHOD FOR THE PRODUCTION OF CYCLIC KETONES | BASF AKTIENGESELLSCHAFT (DE) | 2008-01-03 | — | — | WO | disclosed |
| US-20060281952-A1 | Method for producing a ketone | SCHLUMBERGER TECHNOLOGY CORPORATION | 2006-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100191018-A1 | PROCESS FOR PREPARING PURE CYCLODODECANONE | CCNA1, CYC1, CCNA2 | ALDH1A1 503/4885CDC25B 157/4885TRIM24 3392/4885 |
| US-20100190869-A1 | PROCESS FOR THE ISOLATION OF DODECATRIENAL AND ITS USE AS AROMA SUBSTANCE | CCNA1, OXER1, CCNA2 | ALDH1A1 80/4885CDC25B 778/4885TRIM24 2928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.